We look forward to continuing to demonstrate this in the quarters and years to come. Two final notes on scheduling before I turn things over to Steve. Out of respect for our friends in the federal government who could not attend our previously scheduled quantum sensing conference in October due to the government shutdown, we moved the conference to January 14th to 16th in New York City. We have an excellent agenda that will cover quantum policy, multiple military missions that envision utilizing quantum technology application research from leading national and academic labs, as well as updates on clock and oscillator applications. We look forward to hosting this event next month and gathering many of the leading players in the industry, many of whom we're already working with to build out our quantum future.

Dec 11, 2025 / receipt

We look forward to continuing to demonstrate this in the quarters and years to come. Two final notes on scheduling before I turn things over to Steve. Out of respect for our friends in the federal government who could not attend our previously scheduled quantum sensing conference in October due to the government shutdown, we moved the conference to January 14th to 16th in New York City. We have an excellent agenda that will cover quantum policy, multiple military missions that envision utilizing quantum technology application research from leading national and academic labs, as well as updates on clock and oscillator applications. We look forward to hosting this event next month and gathering many of the leading players in the industry, many of whom we're already working with to build out our quantum future.

Dec 11, 2025 / receipt, needs a key / Thomas McClelland, CEO | earnings call 2025-12-11 | transcript 8885d7c0-a19c-433c-870f-a16f4b0111ba | chars 7149-7968 | segment 6

SG&A as a percentage of revenue decreased 8% versus the same period of the prior year demonstrating positive operating leverage as a result of strategic headcount additions and process optimizations implemented over the prior year.

filing / Sep 14, 2026 / receipt

as a percentage of revenue decreased 8% versus the same period of the prior year demonstrating positive operating leverage as a result

filing / Sep 14, 2026 / receipt

of strategic headcount additions and process optimizations implemented over the prior year. Research and Development Expenses Three Months ended July 31, (in thousands) 2026 2025 Change $ 1,445 $ 1,133 $ 312 27.5 % Research and Development (“R&D”) expenditures represent investments intended to keep the Company’s products at the leading edge of time and frequency technology and to enhance future

filing / Sep 14, 2026 / receipt

Thomas McClelland President and Chief Executive Officer of the Company

filing / Aug 28, 2026 / receipt

Russell M. Sarachek Managing Director of Contra Capital Management, LLC 63 2016

filing / Aug 28, 2026 / receipt

Oleandro Mancini - Senior Vice President, Business Development

filing / Aug 28, 2026 / receipt

Steven L. Bernstein - Chief Financial Officer, Secretary and Treasurer

filing / Aug 28, 2026 / receipt